ArticleBlood advances2023

Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia.

Shai Shimony et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.